Phase 1 study to evaluate the safety and efficacy of jyuzentaihoto in infantile anal fistula
Phase 1
- Conditions
- infantile anal fistula
- Registration Number
- JPRN-UMIN000021336
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Any of the following: currently receiving a drug therapy, currently having chronic diseases such as heart, lung, kidney, gastrointestinal, and inflammatory diseases, suffering from invasive cancer within five years, suffering from non-invasive cancer within a year, and having taken Kampo medicine within 2 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of cure after two and four weeks
- Secondary Outcome Measures
Name Time Method The influence on gut flora and the safety after the administration of jyuzentaihoto